Biomanufacturing viral detection and quantification Market to Grow with a CAGR of 9.14% through 2030

Rising awareness of viral diseases is  the major drivers for the Global Biomanufacturing Viral Detection and Quantifications Market growth in the forecast period, 2026-2030.

According to TechSci Research report, “Biomanufacturing Viral Detection and Quantifications Market –Global Industry Size, Share, Trends, Competition, Opportunity and Forecast, 2030F”, Global Biomanufacturing Viral Detection and Quantifications Market stood at USD 493.46 Million in 2024 and is anticipated to project robust growth in the forecast period with a CAGR of 9.14% through 2030. the Global Increasing demand for biopharmaceuticals Market is anticipated to register a high CAGR during the forecast period. This can be ascribed to collaborations and partnerships among leading companies with a diverse approach to merge the expertise of individual companies and to strengthen their position in the market.

Biomanufacturing viral detection and quantification involves the production and utilization of tools, reagents, and assays to identify and measure the presence of viral pathogens in various samples. This process plays a crucial role in several important applications across different sectors. Significant growth in the healthcare industry across the globe represents one of the key factors creating a positive outlook for the market. Furthermore, Advancements in Diagnostic Technologies and Increased R&D Activities are also driving the market growth. These apparel industries are consumer-based, contributing to the economy by providing trade along the Clinical Diagnostics and infectious disease surveillance and Blood and Blood Products Safety. Such growing global burden of viral disease and the use of Biomanufacturing Viral Detection and Quantifications lead to the increasing demand for Biomanufacturing Viral Detection and Quantifications Market.

Biomanufacturing viral detection and quantification technologies are used in a wide range of settings and industries to detect, identify, and quantify viral pathogens. Rapid infrastructural development across the globe represents one of the key factors stimulating the growth of the market. Moreover, leading players operating in the industry are focusing on product innovations to offer a better customer experience. They are also engaging in partnerships and collaborations to increase their brand presence. Apart from this, Medical laboratories and healthcare facilities use these tools for diagnosing viral infections in patients. They are essential for accurate and timely identification of the viral cause of illnesses.

Moreover, there is a considerable rise in the number of Public health agencies and research institutions use viral detection methods to monitor and track the prevalence of viral infections within populations. This helps in understanding disease trends, planning interventions, and controlling outbreaks. This, along with the rising demand for viral detection tools are used to screen blood donations and ensure the safety of blood and blood-derived products to prevent the transmission of bloodborne viruses, is driving the market. Governments around the world have taken various initiatives to support and advance the global biomanufacturing viral detection and quantification market.

These initiatives are aimed at strengthening public health, enhancing disease surveillance, promoting research and innovation, and ensuring preparedness for infectious disease outbreaks. There is a growing emphasis on Collaboration with Industry within the healthcare industry, with Governments collaborating with biomanufacturing companies to support the production of viral detection reagents, kits, and assays. Public-private partnerships can enhance capacity and promote technology transfer. Collaboration in the global biomanufacturing viral detection and quantification market aims to bring together diverse expertise, resources, and capabilities from various stakeholders to address complex challenges, accelerate innovation, and enhance the development, production, and deployment of viral detection technologies.

Additionally, Global Health Security Agenda (GHSA) is an international partnership of governments, organizations, and institutions working to strengthen global health security and prevent the spread of infectious diseases. It focuses on building capacities for rapid detection, response, and containment of outbreaks, including support for biomanufacturing viral detection technologies. Many governments allocate funding and resources to establish and strengthen public health emergency preparedness and response programs. These programs may include the development of rapid and accurate viral detection methods and the establishment of laboratory networks.

Browse over XX market data Figures and spread through XX Pages and an in-depth TOC on "Global Biomanufacturing Viral Detection and Quantifications Market."

The Global Biomanufacturing Viral Detection and Quantifications Market segmentation is based on Offering Type, Technology, Application, End-User, By Company, and Region.

Based on technology, ELISA (Enzyme-Linked Immunosorbent Assay) is expected to grow at the fastest rate in the biomanufacturing viral detection and quantification market due to its high sensitivity, specificity, and versatility in detecting viral antigens or antibodies. ELISA is widely used in both clinical diagnostics and research settings for rapid, reliable viral detection. Its cost-effectiveness, ease of automation, and suitability for high-throughput screening make it ideal for large-scale testing, particularly in pandemic preparedness and surveillance. Furthermore, advancements in ELISA formats—such as multiplex ELISA and point-of-care adaptations—are expanding its applications in remote and resource-limited settings. Continuous innovation and increasing demand for accurate immunodiagnostics further propel ELISA's dominance in the market.

Based on region, Asia Pacific is growing exponentially in the biomanufacturing viral detection and quantification market due to a surge in infectious disease outbreaks, increasing investments in biotechnology, and growing awareness of early disease diagnosis. Countries like China, India, South Korea, and Japan are strengthening their diagnostic infrastructure, supported by government initiatives and public-private collaborations. The region's large population base and rising healthcare expenditure further boost demand for rapid and scalable viral detection solutions. Additionally, local production of reagents and diagnostic kits, along with rising adoption of advanced technologies such as PCR, ELISA, and biosensors, is accelerating the market’s growth trajectory across Asia Pacific.

Some of the major companies operating in the Global Biomanufacturing Viral Detection and Quantifications Market include:

• Danaher Corporation
• Merck KGaA
• New England Biolabs
• TAKARA HOLDINGS INC.
• Thermo Fisher Scientific Inc.
• Agilent Technologies, Inc.
• Sartorius AG
• Charles River Laboratories
• Bio-Rad Laboratories, Inc.
• PerkinElmer, Inc

Download Free Sample Report

Customers can also request for 10% free customization on this report.

“Certain regions, particularly the Asia Pacific, are projected to exert significant demand for Biomanufacturing Viral Detection and Quantifications worldwide. The growth in the competitive landscape and the presence of well-established companies in the market, committed to enhancing their Biomanufacturing Viral Detection and Quantifications each year, are expected to contribute to a remarkable growth of the Global Dyes Market in the forecast period," said Mr. Karan Chechi, Research Director of TechSci Research, a research-based Global management consulting firm.

"Biomanufacturing Viral Detection and Quantifications Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Offering Type (Consumables, Instruments, Services), By Technology (PCR, ELISA, Flow Cytometry, Plaque Assay, Others), By Application (Blood and Blood Products Manufacturing, Vaccines and Therapeutics Manufacturing, Cellular and Gene Therapy Products Manufacturing, Stem Cell Products Manufacturing, Tissue and Tissue Products Manufacturing), By End-User (Life Science Companies, Testing Laboratories, CROs, CDMOs), By Region and Competition, 2020-2030F," has evaluated the future growth potential of Global Biomanufacturing Viral Detection and Quantifications Market and provides statistics & information on market size, structure, and future market growth. The report intends to provide innovative market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Biomanufacturing Viral Detection and Quantifications Market.

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]

Website: www.techsciresearch.com